Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1425.450.05 (+0 %)

PREV CLOSE ( ) 1425.40

OPEN PRICE ( ) 1425.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16990

TODAY'S LOW / HIGH ( )1403.05 1455.00

52 WK LOW / HIGH ( )890 1577.5

NSE1425.20-0.5 (-0.04 %)

PREV CLOSE( ) 1425.70

OPEN PRICE ( ) 1425.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1425.20 (893)

VOLUME 215470

TODAY'S LOW / HIGH( ) 1402.60 1458.00

52 WK LOW / HIGH ( )889 1580

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

21162.45

19626.3

20019.84

18151.38

Total Expenditure

17138.45

16080.23

16211.11

14788.23

PBIDT (Excl OI)

4024

3546.07

3808.73

3363.15

Other Income

44.53

38.96

356.54

234.41

Operating Profit

4068.53

3585.03

4165.27

3597.56

Interest

390.25

317.78

462.21

587.6

Exceptional Items

-103.78

PBDT

3574.5

3267.25

3703.06

3009.96

Depreciation

968.37

968.06

968.96

935.89

Profit Before Tax

2606.13

2299.19

2734.1

2074.07

Tax

633.76

738.28

718.61

548.17

Provisions and contingencies

Profit After Tax

1972.37

1560.91

2015.49

1525.9

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1972.37

1560.91

2015.49

1525.9

Minority Interest

-82.8

-23.69

-69.77

-85.09

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1889.57

1537.22

1945.72

1440.81

Equity Capital

1894.83

1894.32

1890.98

1811.52

Face Value (IN RS)

Reserves

Calculated EPS

9.97

8.11

10.28

7.95

Calculated EPS (Annualised)

39.88

32.45

41.15

31.81

No of Public Share Holdings

41834065

41782565

41449065

% of Public Share Holdings

22.08

22.06

21.92

PBIDTM% (Excl OI)

19.01

18.06

19.02

18.52

PBIDTM%

19.22

18.26

20.80

19.81

PBDTM%

16.89

16.64

18.49

16.58

PBTM%

12.31

11.71

13.65

11.42

PATM%

9.32

7.95

10.06

8.40

Notes

Risk Disclosures on Derivatives

Quarterly Results

EMCURE PHARMACEUTICALS LTD.